Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: J Neurochem. 2009 Oct 8;111(6):1478. doi: 10.1111/j.1471-4159.2009.06425.x

Fig 3. Adenosine A2A receptor antagonist SCH58261 counteracts astroglia activation in the SNc and Str.

Fig 3

(A) shows representative sections immunostained for GFAP, from SNc (upper images) and Str (lower images) of mice sacrificed 3 days after MPTP treatment. Mice were treated as described in Fig 1. (B) shows analysis of GFAP immunostaining 1, 3, 7 days after MPTP, reported as percentage of GFAP-positive cells as compared to vehicle-treated mice in the SNc (left graph) and in the Str (right graph). * indicates p<0.001 versus corresponding vehicle and MPTP+SCH58261 groups; # indicates p<0.001 versus corresponding MPTP group, by Tukey’s post hoc test. Scale bar: 50 μm.